The inflammatory consequences of psychologic stress: Relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II

Black, 2002, Stress and the inflammatory response: a review of neurogenic inflammation, Brain Behav Immun, 16, 622, 10.1016/S0889-1591(02)00021-1

Maier, 1998, Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition, Psychol Rev, 105, 83, 10.1037/0033-295X.105.1.83

Seematter, 2004, Relationship between stress, inflammation and metabolism, Curr Opin Clin Nutr Metab Care, 7, 169, 10.1097/00075197-200403000-00011

McCarty, 1999, Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline, Med Hypotheses, 52, 465, 10.1054/mehy.1997.0684

Morimoto, 1987, Restraint induced stress elicits acute-phase response in rabbits, Pflugers Arch, 410, 554, 10.1007/BF00586538

Pahl, 1999, Activators and target genes of Rel/NF-kappaB transcription factors, Oncogene, 18, 6853, 10.1038/sj.onc.1203239

Bierhaus, 2003, A mechanism converting psychosocial stress into mononuclear cell activation, Proc Natl Acad Sci USA, 100, 1920, 10.1073/pnas.0438019100

Rhen, 2005, Antiinflammatory action of glucocorticoids—new mechanisms for old drugs, New Engl J Med, 353, 1711, 10.1056/NEJMra050541

Ghanim, 2004, Circulating mononuclear cells in the obese are in a proinflammatory state, Circulation, 110, 1564, 10.1161/01.CIR.0000142055.53122.FA

Black, 2003, The inflammatory response is an integral part of the stress response: implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X, Brain Behav Immun, 17, 350, 10.1016/S0889-1591(03)00048-5

Brindley, 1989, Possible connections between stress, diabetes, obesity, hypertension and altered lipoprotein metabolism that may result in atherosclerosis, Clin Sci (Lond), 77, 453, 10.1042/cs0770453

Kullo, 2004, Association between metabolic syndrome and subclinical coronary atherosclerosis in asymptomatic adults, Am J Cardiol, 94, 1554, 10.1016/j.amjcard.2004.08.038

Palatini, 2001, Sympathetic overactivity in hypertension: a risk factor for cardiovascular disease, Curr Hypertens Rep, 3, S3, 10.1007/s11906-001-0065-z

Pliquett, 2004, Neurohumoral stimulation in type-2-diabetes as an emerging disease concept, Cardiovasc Diabetol, 3

Julius, 1994, Sympathetics, insulin resistance and coronary risk in hypertension: the ’chicken-and-egg’ question, J Hypertens, 12, 495, 10.1097/00004872-199405000-00001

Julius, 1991, The hemodynamic link between insulin resistance and hypertension, J Hypertens, 9, 983, 10.1097/00004872-199111000-00001

Serne, 1999, Microvascular function relates to insulin sensitivity and blood pressure in normal subjects, Circulation, 99, 896, 10.1161/01.CIR.99.7.896

de Jongh, 2004, Free fatty acid levels modulate microvascular function: relevance for obesity-associated insulin resistance, hypertension, and microangiopathy, Diabetes, 53, 2873, 10.2337/diabetes.53.11.2873

Neutel, 2004, Effect of the renin–angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function, J Hum Hypertens, 18, 599, 10.1038/sj.jhh.1001714

Mattacks, 1999, Interactions of noradrenalin and tumour necrosis factor alpha, interleukin 4 and interleukin 6 in the control of lipolysis from adipocytes around lymph nodes, Cytokine, 11, 334, 10.1006/cyto.1998.0442

Marz, 1998, Sympathetic neurons can produce and respond to interleukin 6, Proc Natl Acad Sci USA, 95, 3251, 10.1073/pnas.95.6.3251

Brunner, 2002, Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study, Circulation, 106, 2659, 10.1161/01.CIR.0000038364.26310.BD

Kusunoki, 1995, Amelioration of high-fat feeding-induced insulin resistance in skeletal muscle with the antiglucocorticoid RU486, Diabetes, 44, 718, 10.2337/diabetes.44.6.718

Green, 1997, Negative feedback neuroendocrine control of inflammatory response in the rat is dependent on the sympathetic postganglionic neuron, J Neurosci, 17, 3234, 10.1523/JNEUROSCI.17-09-03234.1997

Munck, 1994, Glucocorticoids and stress: permissive and suppressive actions, Ann N Y Acad Sci, 746, 115, 10.1111/j.1749-6632.1994.tb39221.x

Fain, 1983, Adrenergic regulation of adipocyte metabolism, J Lipid Res, 24, 945, 10.1016/S0022-2275(20)37910-4

Tomlinson, 2001, Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines, Endocrinology, 142, 1982, 10.1210/en.142.5.1982

Kotelevtsev, 1999, Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2, J Clin Invest, 103, 683, 10.1172/JCI4445

Hermanowski-Vosatka, 2005, 11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice, J Exp Med, 202, 517, 10.1084/jem.20050119

Bjorntorp, 1991, Metabolic implications of body fat distribution, Diabetes Care, 14, 1132, 10.2337/diacare.14.12.1132

Raikkonen, 1996, Psychosocial stress and the insulin resistance syndrome, Metabolism, 45, 1533, 10.1016/S0026-0495(96)90184-5

Kahl, 2005, Visceral fat deposition and insulin sensitivity in depressed women with and without comorbid borderline personality disorder, Psychosom Med, 67, 407, 10.1097/01.psy.0000160458.95955.f4

Black, 2002, Stress, inflammation and cardiovascular disease, J Psychosom Res, 52, 1, 10.1016/S0022-3999(01)00302-6

Clement, 1995, Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity, New Engl J Med, 333, 352, 10.1056/NEJM199508103330605

Shaw, 2005, Metabolic syndrome: what is it and what are the implications, Proc Nutr Soc, 64, 349, 10.1079/PNS2005442

Barter, 2004, Antiinflammatory properties of HDL, Circ Res, 95, 764, 10.1161/01.RES.0000146094.59640.13

Boden, 2002, Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction, Eur J Clin Invest, 32, 14, 10.1046/j.1365-2362.32.s3.3.x

Caglayan, 2005, Metabolic syndrome-interdependence of the cardiovascular and metabolic pathways, Curr Opin Pharmacol, 5, 135, 10.1016/j.coph.2005.01.008

Ghiadoni, 2000, Mental stress induces transient endothelial dysfunction in humans, Circulation, 102, 2473, 10.1161/01.CIR.102.20.2473

Balletshofer, 2003, Insulin resistant young subjects at risk of accelerated atherosclerosis exhibit a marked reduction in peripheral endothelial function early in life but not differences in intima-media thickness, Atherosclerosis, 171, 303, 10.1016/j.atherosclerosis.2003.08.013

Das, 2004, Metabolic syndrome X: an inflammatory condition?, Curr Hypertens Rep, 6, 66, 10.1007/s11906-004-0014-8

Cleland, 2000, Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease, Clin Sci (Lond), 98, 531, 10.1042/CS20000013

Reaven, 2002, Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease, Circulation, 106, 286, 10.1161/01.CIR.0000019884.36724.D9

Julius, 1992, White coat hypertension: a follow-up, Clin Exp Hypertens A, 14, 45, 10.3109/10641969209036170

Esler, 2000, Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease, J Cardiovasc Pharmacol, 35, S1, 10.1097/00005344-200000004-00001

Chae, 2001, Blood pressure and inflammation in apparently healthy men, Hypertension, 38, 399, 10.1161/01.HYP.38.3.399

Doo, 2004, Associations among oxidized low-density lipoprotein antibody, C-reactive protein, interleukin-6, and circulating cell adhesion molecules in patients with unstable angina pectoris, Am J Cardiol, 93, 554, 10.1016/j.amjcard.2003.11.017

Wassmann, 2004, Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor, Circ Res, 94, 534, 10.1161/01.RES.0000115557.25127.8D

Fernandez-Real, 2001, Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women, J Clin Endocrinol Metab, 86, 1154, 10.1210/jc.86.3.1154

Wheatcroft, 2003, Pathophysiological implications of insulin resistance on vascular endothelial function, Diabet Med, 20, 255, 10.1046/j.1464-5491.2003.00869.x

Ross, 1999, Atherosclerosis—an inflammatory disease, New Engl J Med, 340, 115, 10.1056/NEJM199901143400207

Orr, 2005, The subendothelial extracellular matrix modulates NF-kappaB activation by flow: a potential role in atherosclerosis, J Cell Biol, 169, 191, 10.1083/jcb.200410073

Mullaly, 2004, Toll gates and traffic arteries: from endothelial TLR2 to atherosclerosis, Circ Res, 95, 657, 10.1161/01.RES.0000144806.19585.5b

Hingorani, 2000, Acute systemic inflammation impairs endothelium-dependent dilatation in humans, Circulation, 102, 994, 10.1161/01.CIR.102.9.994

Bhagat, 1997, Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo, Circulation, 96, 3042, 10.1161/01.CIR.96.9.3042

Grekin, 1995, Pressor effects of portal venous oleate infusion. A proposed mechanism for obesity hypertension., Hypertension, 26, 193, 10.1161/01.HYP.26.1.193

Lutz, 1996, Intraportal infusion of 2,5-anhydro-d-mannitol increases afferent activity in the common hepatic vagus branch, J Autonom Nerv Sys, 61, 204, 10.1016/S0165-1838(96)00079-3

Niijima, 1998, Afferent signals from leptin sensors in the white adipose tissue of the epididymis, and their reflex effect in the rat, J Autonom Nerv Syst, 73, 19, 10.1016/S0165-1838(98)00109-X

Xu, 2003, Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance, J Clin Invest, 112, 1821, 10.1172/JCI200319451

Wellen, 2003, Obesity-induced inflammatory changes in adipose tissue, J Clin Invest, 112, 1785, 10.1172/JCI20514

Lin, 2001, Hyperglycemia-induced production of acute phase reactants in adipose tissue, J Biol Chem, 276, 42077, 10.1074/jbc.M107101200

Engstrom, 2003, Inflammation-sensitive plasma proteins are associated with future weight gain, Diabetes, 52, 2097, 10.2337/diabetes.52.8.2097

Weisberg, 2003, Obesity is associated with macrophage accumulation in adipose tissue, J Clin Invest, 112, 1796, 10.1172/JCI200319246

Werner, 2004, From fat fighter to risk factor: the zigzag trek of leptin, Arterioscl Thromb Vasc Biol, 24, 7, 10.1161/01.ATV.0000110908.43721.ad

Ouchi, 2003, Obesity, adiponectin and vascular inflammatory disease, Curr Opin Lipidol, 14, 561, 10.1097/00041433-200312000-00003

Stern, 1995, Diabetes and cardiovascular disease. The “common soil” hypothesis, Diabetes, 44, 369, 10.2337/diabetes.44.4.369

Dominiczak, 2003, Obesity, glucose intolerance and diabetes and their links to cardiovascular disease. Implications for laboratory medicine, Clin Chem Lab Med, 41, 1266, 10.1515/CCLM.2003.194

Ruderman, 1998, The metabolically obese, normal-weight individual revisited, Diabetes, 47, 699, 10.2337/diabetes.47.5.699

Bjorntorp, 1999, Hypothalamic origin of the metabolic syndrome X, Ann NY Acad Sci, 892, 297, 10.1111/j.1749-6632.1999.tb07803.x

Bjorntorp, 2001, Do stress reactions cause abdominal obesity and comorbidities?, Obes Rev, 2, 73, 10.1046/j.1467-789x.2001.00027.x

Wright, 2000, Infectious agents are not necessary for murine atherogenesis, J Exp Med, 191, 1437, 10.1084/jem.191.8.1437

Lau, 2005, Adipokines: molecular links between obesity and atheroslcerosis, Am J Physiol Heart Circ Physiol, 288, H2031, 10.1152/ajpheart.01058.2004

Matsuzawa, 2004, Adiponectin and metabolic syndrome, Arterioscl Thromb Vasc Biol, 24, 29, 10.1161/01.ATV.0000099786.99623.EF

Lehrke, 2004, An inflammatory cascade leading to hyperresistinemia in humans, PLoS Med, 1, e45, 10.1371/journal.pmed.0010045

Zoccali, 2005, Neuropeptide Y as a far-reaching neuromediator: from energy balance and cardiovascular regulation to central integration of weight and bone mass control mechanisms. Implications for human diseases, Curr Opin Nephrol Hypertens, 14, 25, 10.1097/00041552-200501000-00005

Dallman, 2005, Chronic stress and comfort foods: self-medication and abdominal obesity, Brain Behav Immun, 19, 275, 10.1016/j.bbi.2004.11.004

Lindmark, 2003, Does the autonomic nervous system play a role in the development of insulin resistance? A study on heart rate variability in first-degree relatives of Type 2 diabetes patients and control subjects, Diabet Med, 20, 399, 10.1046/j.1464-5491.2003.00920.x

Bouloumie, 2005, Role of macrophage tissue infiltration in metabolic diseases, Curr Opin Clin Nutr Metab Care, 8, 347, 10.1097/01.mco.0000172571.41149.52

Tannock, 2005, Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects, Circulation, 111, 3058, 10.1161/CIRCULATIONAHA.104.506188

Wisse, 2004, The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity, J Am Soc Nephrol, 15, 2792, 10.1097/01.ASN.0000141966.69934.21

Rahmouni, 2001, Leptin signaling pathways in the central nervous system: interactions between neuropeptide Y and melanocortins, Bioessays, 23, 1095, 10.1002/bies.10018

Lam, 2005, Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis, Nat Med, 11, 320, 10.1038/nm1201

Troseid, 2004, Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome, Eur Heart J, 25, 349, 10.1016/j.ehj.2003.12.006

Olefsky, 1974, Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects, J Clin Invest, 53, 64, 10.1172/JCI107560

Steinberg, 1997, Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation, J Clin Invest, 100, 1230, 10.1172/JCI119636

Hall, 1993, Obesity-induced hypertension. Renal function and systemic hemodynamics, Hypertension, 22, 292, 10.1161/01.HYP.22.3.292

Esposito, 2003, Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial, JAMA, 289, 1799, 10.1001/jama.289.14.1799

Esposito, 2002, Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress, Circulation, 106, 2067, 10.1161/01.CIR.0000034509.14906.AE

Dandona, 2001, The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation, J Clin Endocrinol Metab, 86, 355, 10.1210/jc.86.1.355

Clement, 2004, Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects, FASEB J, 18, 1657, 10.1096/fj.04-2204com

Kelley, 2004, Thermodynamics, liposuction, and metabolism, New Engl J Med, 350, 2542, 10.1056/NEJMp048115

Ramos, 2003, Is obesity an inflammatory disease?, Surgery, 134, 329, 10.1067/msy.2003.267

Karbowska, 2005, Effect of DHEA on endocrine functions of adipose tissue, the involvement of PPAR gamma, Biochem Pharmacol, 70, 249, 10.1016/j.bcp.2005.04.022

Ziegler, 2005, Type 2 diabetes as an inflammatory cardiovascular disorder, Curr Mol Med, 5, 309, 10.2174/1566524053766095

Gould, 1982, Darwinism and the expansion of evolutionary theory, Science, 216, 380, 10.1126/science.7041256